Health Idea Now
Monday, 25 November 2019
Adamis shares slump as FDA declines to approve opioid overdose treatment
Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, Zimhi, sending its shares plunging 56%.
from Reuters: Health News https://ift.tt/2KSA4EZ
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment